These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


290 related items for PubMed ID: 29110611

  • 21. Evaluation of the Effect of Everolimus on Retinal Pigment Epithelial Cells and Experimental Proliferative Vitreoretinopathy.
    Kuo HK, Chen YH, Kuo YH, Ke MC, Tseng YC, Wu PC.
    Curr Eye Res; 2018 Mar; 43(3):333-339. PubMed ID: 29182404
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Blockade of Jagged/Notch pathway abrogates transforming growth factor β2-induced epithelial-mesenchymal transition in human retinal pigment epithelium cells.
    Chen X, Xiao W, Liu X, Zeng M, Luo L, Wu M, Ye S, Liu Y.
    Curr Mol Med; 2014 May; 14(4):523-34. PubMed ID: 24694299
    [Abstract] [Full Text] [Related]

  • 24. Long noncoding RNA ERLR mediates epithelial-mesenchymal transition of retinal pigment epithelial cells and promotes experimental proliferative vitreoretinopathy.
    Yang S, Li H, Yao H, Zhang Y, Bao H, Wu L, Zhang C, Li M, Feng L, Zhang J, Zheng Z, Xu G, Wang F.
    Cell Death Differ; 2021 Aug; 28(8):2351-2366. PubMed ID: 33664479
    [Abstract] [Full Text] [Related]

  • 25. Overexpression p21WAF1/CIP1 in suppressing retinal pigment epithelial cells and progression of proliferative vitreoretinopathy via inhibition CDK2 and cyclin E.
    Wang Y, Yuan Z, You C, Han J, Li H, Zhang Z, Yan H.
    BMC Ophthalmol; 2014 Nov 25; 14():144. PubMed ID: 25421815
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Bone morphogenetic protein 6 (BMP6) antagonises experimental proliferative vitreoretinopathy established by TGF-β2 stimulation in retinal pigment epithelial cells through modulation of the p38 and JNK MAPK pathways.
    Liu X, Liu M, Chen L.
    Cell Tissue Res; 2024 Apr 25; 396(1):103-117. PubMed ID: 38403744
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Inhibitory Effects of Plumbagin on Retinal Pigment Epithelial Cell Epithelial-Mesenchymal Transition In Vitro and In Vivo.
    Chen H, Wang H, An J, Shang Q, Ma J.
    Med Sci Monit; 2018 Mar 13; 24():1502-1510. PubMed ID: 29532788
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The polyether ionophore salinomycin targets multiple cellular pathways to block proliferative vitreoretinopathy pathology.
    Heffer AM, Proaño J, Roztocil E, Phipps RP, Feldon SE, Huxlin KR, Sime PJ, Libby RT, Woeller CF, Kuriyan AE.
    PLoS One; 2019 Mar 13; 14(9):e0222596. PubMed ID: 31527897
    [Abstract] [Full Text] [Related]

  • 34. Thrombin induces epithelial-mesenchymal transition and collagen production by retinal pigment epithelial cells via autocrine PDGF-receptor signaling.
    Bastiaans J, van Meurs JC, van Holten-Neelen C, Nagtzaam NM, van Hagen PM, Chambers RC, Hooijkaas H, Dik WA.
    Invest Ophthalmol Vis Sci; 2013 Dec 19; 54(13):8306-14. PubMed ID: 24302586
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Nintedanib inhibits normal human vitreous-induced epithelial-mesenchymal transition in human retinal pigment epithelial cells.
    Yin Y, Liu S, Liu H, Wu W.
    Biomed Pharmacother; 2023 Oct 19; 166():115403. PubMed ID: 37659204
    [Abstract] [Full Text] [Related]

  • 38. Substance P prevents development of proliferative vitreoretinopathy in mice by modulating TNF-α.
    Yoo K, Son BK, Kim S, Son Y, Yu SY, Hong HS.
    Mol Vis; 2017 Oct 19; 23():933-943. PubMed ID: 29296073
    [Abstract] [Full Text] [Related]

  • 39. Activated Blood Coagulation Factor X (FXa) Contributes to the Development of Traumatic PVR Through Promoting RPE Epithelial-Mesenchymal Transition.
    Han H, Zhao X, Liao M, Song Y, You C, Dong X, Yang X, Wang X, Huang B, Du M, Yan H.
    Invest Ophthalmol Vis Sci; 2021 Jul 01; 62(9):29. PubMed ID: 34283209
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.